India Equity: Suven_Pharma (#SUVENPHAR) declares Quarterly Results. EPS = Rs 3.27 for quarter ended Mar 2021

0
415

SUVENPHAR has declared results for the period ended Mar 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Login below to read further [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Mar 2021 is Rs 259.0 cr compared to Rs 185.0 cr for period ended Mar 2020, a rise of 40.0%
  • Operating Profits reported at Rs 94.0 cr for period ended Mar 2021 vis-vis 77.0 for period ended Mar 2020 .
  • Operating Margins contracted -532.8 bps for period ended Mar 2021 vis-vis Mar 2020 .
  • The EPS for Mar 2021 was Rs 3.27 compared to Rs 4.46 for previous quarter ended Dec 2020 and Rs 2.91 for Mar 2020
  • The stock is trading at Rs 516 and a market cap of Rs 13130 cr

[/s2If]

Price Chart

Further analysis and Full Company Research with investing scores is available here: SUVENPHAR

Join Our Telegram Group
Join Our Twitter

This site uses Akismet to reduce spam. Learn how your comment data is processed.